Viking Global Investors LP Rallybio Corp Transaction History
Viking Global Investors LP
- $25.1 Billion
- Q2 2024
A detailed history of Viking Global Investors LP transactions in Rallybio Corp stock. As of the latest transaction made, Viking Global Investors LP holds 4,194,777 shares of RLYB stock, worth $4.66 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,194,777
Previous 4,194,777
-0.0%
Holding current value
$4.66 Million
Previous $7.76 Million
27.56%
% of portfolio
0.02%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding RLYB
# of Institutions
68Shares Held
32.2MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ3.64MShares$4.04 Million1.68% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$4.03 Million2.28% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$3.66 Million5.39% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$3.36 Million0.1% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA2.4MShares$2.67 Million2.9% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $35.7M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...